Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAMK2G antisense RNA 1 (CAMK2G-AS1) is presumed to be a non-coding RNA, transcribed from the region antisense to the CAMK2G gene. As of current curated knowledge, it has not been functionally characterized in experimental literature or databases, is not established as a therapeutic target, biomarker, or molecular mechanism of disease. All existing disease association and mechanism data concern the protein-coding gene CAMK2G, which encodes the gamma isoform of calcium/calmodulin-dependent protein kinase II with critical roles in neurodevelopment, neuronal maturation, plasticity, and some forms of intellectual disability[1][3][2]. There is no evidence that CAMK2G-AS1 is involved in these processes or is actionable in drug discovery or clinical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CAMK2G antisense RNA 1 (CAMK2G-AS1).